ENTRY       2261              CDS       T01001
NAME        FGFR3, ACH, CD333, CEK2, HSFGFR3EX, JTK4
DEFINITION  (RefSeq) fibroblast growth factor receptor 3
ORTHOLOGY   K05094  fibroblast growth factor receptor 3 [EC:2.7.10.1]
ORGANISM    hsa  Homo sapiens (human)
PATHWAY     hsa01521  EGFR tyrosine kinase inhibitor resistance
            hsa04010  MAPK signaling pathway
            hsa04014  Ras signaling pathway
            hsa04015  Rap1 signaling pathway
            hsa04144  Endocytosis
            hsa04151  PI3K-Akt signaling pathway
            hsa04550  Signaling pathways regulating pluripotency of stem cells
            hsa04810  Regulation of actin cytoskeleton
            hsa05200  Pathways in cancer
            hsa05206  MicroRNAs in cancer
            hsa05219  Bladder cancer
            hsa05230  Central carbon metabolism in cancer
DISEASE     H00010  Multiple myeloma
            H00022  Bladder cancer
            H00458  Craniosynostosis
            H00505  FGFR3-related short limb skeletal dysplasias
            H00642  Lacrimo-auriculo-dento-digital syndrome (LADD)
            H00997  CATSHL syndrome
            H01749  Achondroplasia
            H01750  Thanatophoric dysplasia
            H01754  Crouzon syndrome
DRUG_TARGET Dovitinib lactate: D08907
            Lenvatinib (DG01362): D09919 D09920
            Nintedanib (DG01374): D10396 D10481
BRITE       KEGG Orthology (KO) [BR:hsa00001]
             Environmental Information Processing
              Signal transduction
               04014 Ras signaling pathway
                2261 (FGFR3)
               04015 Rap1 signaling pathway
                2261 (FGFR3)
               04010 MAPK signaling pathway
                2261 (FGFR3)
               04151 PI3K-Akt signaling pathway
                2261 (FGFR3)
             Cellular Processes
              Transport and catabolism
               04144 Endocytosis
                2261 (FGFR3)
              Cellular community - eukaryotes
               04550 Signaling pathways regulating pluripotency of stem cells
                2261 (FGFR3)
              Cell motility
               04810 Regulation of actin cytoskeleton
                2261 (FGFR3)
             Human Diseases
              Cancers
               05200 Pathways in cancer
                2261 (FGFR3)
               05230 Central carbon metabolism in cancer
                2261 (FGFR3)
               05206 MicroRNAs in cancer
                2261 (FGFR3)
               05219 Bladder cancer
                2261 (FGFR3)
              Drug resistance
               01521 EGFR tyrosine kinase inhibitor resistance
                2261 (FGFR3)
            Enzymes [BR:hsa01000]
             2. Transferases
              2.7  Transferring phosphorus-containing groups
               2.7.10  Protein-tyrosine kinases
                2.7.10.1  receptor protein-tyrosine kinase
                 2261 (FGFR3)
            Protein kinases [BR:hsa01001]
             Tyrosine protein kinases
              FGFR family [OT]
               2261 (FGFR3)
            Enzyme-linked receptors [BR:hsa01020]
             Receptor tyrosine kinases
              RTK class IV (FGF receptor family)
               2261 (FGFR3)
            Cytokine receptors [BR:hsa04050]
             Receptor tyrosine kinase
              RTK class IV (FGF receptor family)
               2261 (FGFR3)
            CD molecules [BR:hsa04090]
             Proteins
              2261 (FGFR3)
POSITION    4p16.3
MOTIF       Pfam: Pkinase_Tyr Pkinase I-set Ig_3 Ig_2 ig V-set C2-set_2 DUF1533
DBLINKS     NCBI-GeneID: 2261
            NCBI-ProteinID: NP_000133
            OMIM: 134934
            HGNC: 3690
            Ensembl: ENSG00000068078
            Vega: OTTHUMG00000121148
            Pharos: P22607(Tclin)
            UniProt: P22607 Q0IJ44
STRUCTURE   PDB: 3GRW 4K33 1RY7 2LZL
AASEQ       806
            MGAPACALALCVAVAIVAGASSESLGTEQRVVGRAAEVPGPEPGQQEQLVFGSGDAVELS
            CPPPGGGPMGPTVWVKDGTGLVPSERVLVGPQRLQVLNASHEDSGAYSCRQRLTQRVLCH
            FSVRVTDAPSSGDDEDGEDEAEDTGVDTGAPYWTRPERMDKKLLAVPAANTVRFRCPAAG
            NPTPSISWLKNGREFRGEHRIGGIKLRHQQWSLVMESVVPSDRGNYTCVVENKFGSIRQT
            YTLDVLERSPHRPILQAGLPANQTAVLGSDVEFHCKVYSDAQPHIQWLKHVEVNGSKVGP
            DGTPYVTVLKTAGANTTDKELEVLSLHNVTFEDAGEYTCLAGNSIGFSHHSAWLVVLPAE
            EELVEADEAGSVYAGILSYGVGFFLFILVVAAVTLCRLRSPPKKGLGSPTVHKISRFPLK
            RQVSLESNASMSSNTPLVRIARLSSGEGPTLANVSELELPADPKWELSRARLTLGKPLGE
            GCFGQVVMAEAIGIDKDRAAKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIIN
            LLGACTQGGPLYVLVEYAAKGNLREFLRARRPPGLDYSFDTCKPPEEQLTFKDLVSCAYQ
            VARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNLDYYKKTTNGRLPVKW
            MAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCT
            HDLYMIMRECWHAAPSQRPTFKQLVEDLDRVLTVTSTDEYLDLSAPFEQYSPGGQDTPSS
            SSSGDDSVFAHDLLPPAPPSSGGSRT
NTSEQ       2421
            atgggcgcccctgcctgcgccctcgcgctctgcgtggccgtggccatcgtggccggcgcc
            tcctcggagtccttggggacggagcagcgcgtcgtggggcgagcggcagaagtcccgggc
            ccagagcccggccagcaggagcagttggtcttcggcagcggggatgctgtggagctgagc
            tgtcccccgcccgggggtggtcccatggggcccactgtctgggtcaaggatggcacaggg
            ctggtgccctcggagcgtgtcctggtggggccccagcggctgcaggtgctgaatgcctcc
            cacgaggactccggggcctacagctgccggcagcggctcacgcagcgcgtactgtgccac
            ttcagtgtgcgggtgacagacgctccatcctcgggagatgacgaagacggggaggacgag
            gctgaggacacaggtgtggacacaggggccccttactggacacggcccgagcggatggac
            aagaagctgctggccgtgccggccgccaacaccgtccgcttccgctgcccagccgctggc
            aaccccactccctccatctcctggctgaagaacggcagggagttccgcggcgagcaccgc
            attggaggcatcaagctgcggcatcagcagtggagcctggtcatggaaagcgtggtgccc
            tcggaccgcggcaactacacctgcgtcgtggagaacaagtttggcagcatccggcagacg
            tacacgctggacgtgctggagcgctccccgcaccggcccatcctgcaggcggggctgccg
            gccaaccagacggcggtgctgggcagcgacgtggagttccactgcaaggtgtacagtgac
            gcacagccccacatccagtggctcaagcacgtggaggtgaatggcagcaaggtgggcccg
            gacggcacaccctacgttaccgtgctcaagacggcgggcgctaacaccaccgacaaggag
            ctagaggttctctccttgcacaacgtcacctttgaggacgccggggagtacacctgcctg
            gcgggcaattctattgggttttctcatcactctgcgtggctggtggtgctgccagccgag
            gaggagctggtggaggctgacgaggcgggcagtgtgtatgcaggcatcctcagctacggg
            gtgggcttcttcctgttcatcctggtggtggcggctgtgacgctctgccgcctgcgcagc
            ccccccaagaaaggcctgggctcccccaccgtgcacaagatctcccgcttcccgctcaag
            cgacaggtgtccctggagtccaacgcgtccatgagctccaacacaccactggtgcgcatc
            gcaaggctgtcctcaggggagggccccacgctggccaatgtctccgagctcgagctgcct
            gccgaccccaaatgggagctgtctcgggcccggctgaccctgggcaagccccttggggag
            ggctgcttcggccaggtggtcatggcggaggccatcggcattgacaaggaccgggccgcc
            aagcctgtcaccgtagccgtgaagatgctgaaagacgatgccactgacaaggacctgtcg
            gacctggtgtctgagatggagatgatgaagatgatcgggaaacacaaaaacatcatcaac
            ctgctgggcgcctgcacgcagggcgggcccctgtacgtgctggtggagtacgcggccaag
            ggtaacctgcgggagtttctgcgggcgcggcggcccccgggcctggactactccttcgac
            acctgcaagccgcccgaggagcagctcaccttcaaggacctggtgtcctgtgcctaccag
            gtggcccggggcatggagtacttggcctcccagaagtgcatccacagggacctggctgcc
            cgcaatgtgctggtgaccgaggacaacgtgatgaagatcgcagacttcgggctggcccgg
            gacgtgcacaacctcgactactacaagaagacaaccaacggccggctgcccgtgaagtgg
            atggcgcctgaggccttgtttgaccgagtctacactcaccagagtgacgtctggtccttt
            ggggtcctgctctgggagatcttcacgctggggggctccccgtaccccggcatccctgtg
            gaggagctcttcaagctgctgaaggagggccaccgcatggacaagcccgccaactgcaca
            cacgacctgtacatgatcatgcgggagtgctggcatgccgcgccctcccagaggcccacc
            ttcaagcagctggtggaggacctggaccgtgtccttaccgtgacgtccaccgacgagtac
            ctggacctgtcggcgcctttcgagcagtactccccgggtggccaggacacccccagctcc
            agctcctcaggggacgactccgtgtttgcccacgacctgctgcccccggccccacccagc
            agtgggggctcgcggacgtga
///
